One of the biggest investor gatherings for established and up-and-coming publicly listed, late-stage private biotech companies is the BIO CEO & Investor Conference. Our goal is to assist the industry as a whole in succeeding, thus we offer a comprehensive and objective perspective on investment prospects.
Every year, the BIO CEO & Investor Conference offers a platform for senior biotechnology executives, industry analysts, and institutional investors to influence the direction of future biotechnology investment, funding promising discoveries that will improve patient outcomes.
